Gemcitabine Hydrochloride
Overview
Gemcitabine Hydrochloride is a nucleoside analog used as chemotherapy. It is primarily utilized in the treatment of various carcinomas, including non-small cell lung cancer and pancreatic cancer.
API suppliers (9)
Suppliers of Gemcitabine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 9 suppliers.
5 of 9 hold a GMP certificate on record in the EU or UK registers · 2 hold a European CEP for this substance
- TAPI NL BVNetherlands1 active DMF
- Laurus Labs LimitedIndiaCEP GMP on record
- FRESENIUS KABI ONCOLOGY LTDIndia GMP on record
- Intas Pharmaceuticals Ltd.IndiaCEP GMP on record
- OLON SPAItaly GMP on record
- EUTICALS SPAItaly
- PharmaEssentiaTaiwan GMP on record
- JARI PHARMACEUTICAL CO LTD
- DISHMAN PHARMACEUTICALS AND CHEMICALS LTD
Chemical identity
- IUPAC name
- 17-ethyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene
- Canonical SMILES
- CCC1CCC2C1(CCC3C2CCC4C3(CCCC4)C)C
- InChIKey
- JWMFYGXQPXQEEM-UHFFFAOYSA-N
Therapeutic areas
Do you supply Gemcitabine Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.